<DOC>
	<DOCNO>NCT02429102</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability pharmacokinetics MT-8554 healthy Caucasian subject .</brief_summary>
	<brief_title>A Study Investigate Safety , Tolerability Pharmacokinetics MT-8554 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy free clinically significant illness disease Male female subject age 18 55 year elderly male subject age ≥65 A body weight ≥60 kg male ≥50 kg female Participation three clinical study involve administration Investigational Medicinal Product ( IMP ) previous year , study within 12 week . Clinically significant endocrine , thyroid , hepatic , respiratory , gastrointestinal , renal , cardiovascular disease , history significant psychiatric/psychotic illness disorder . Clinically relevant abnormal medical history , physical finding laboratory value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>Pharmacokinetics MT-8554</keyword>
</DOC>